Quick Facts at a Glance
- Recall Date
- December 18, 2025
- Hazard Level
- HIGH
- Brand
- Imprimis NJOF
- Category
- Health & Personal Care
- Sold At
- Unknown
- Geographic Scope
- 1 states
- At-Risk Groups
- GENERAL
What to Do Now
Use this page like a recall checklist: verify the product first, then act on the official remedy.
Immediate steps
- 1Stop using the product until you confirm whether it is included in the recall.
- 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
- 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
- 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.
Check these identifiers
- Brand
- Imprimis NJOF
- Product type
- Single-Use Intraocular Injection
- Model numbers
- Lot: 25APR001A, 25APR001B
- Sold at
- Unknown
- Where affected
- ALL
Recall Timeline
Key dates and source checks for this recall record.
Recall announced
December 18, 2025
Reported by FDA DRUG
January 14, 2026
RecallRadar source check
January 21, 2026
Consumer action
Use the official remedy and keep documentation.
Hazard Information
Presence of particulate matter - Glass like particles.
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact Imprimis NJOF, LLC or your healthcare provider for guidance. Notification method: Letter
About This Product
Dexamethasone Moxifloxacin Ketorolac is a combination medication used for intraocular injections, primarily in ophthalmic procedures. Consumers purchase these injections for their efficacy in treating various eye conditions.
Why This Is Dangerous
The presence of glass-like particles in the injection can lead to significant health risks if injected. These particles may cause inflammation or other serious complications in the eye.
Industry Context
This recall is not part of a broader industry pattern.
Real-World Impact
Consumers may face health risks if they have used the product, necessitating immediate action and consultation with healthcare providers.
Practical Guidance
How to identify if yours is affected
- Check the lot number on the packaging against the recalled lots: 25APR001A and 25APR001B.
- Inspect the product for any visible particulate matter.
- Contact your healthcare provider to verify if you have the affected product.
Where to find product info
Lot numbers can typically be found on the product packaging or labeling.
What timeline to expect
Expect processing timelines for refunds or replacements to take approximately 4-6 weeks.
If the manufacturer is unresponsive
- Contact Imprimis NJOF directly for follow-up.
- Document all communication and keep records of your inquiry.
How to prevent similar issues
- When purchasing injectable medications, inquire about the safety and quality certifications.
- Always check for recalls on medications before use.
- Consult healthcare professionals for alternative treatments if recalls are issued.
Documentation advice
Keep receipts, packaging, and correspondence regarding the product for your records.
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Product Details
The recalled product is Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL, with model numbers Lot: 25APR001A and 25APR001B. The expiration date is April 3, 2026. The product was distributed nationwide in the U.S.
Key Facts
- Recalled brand: Imprimis NJOF
- Total units recalled: 596 boxes
- Each box contains 11,920 pre-filled syringes
- Recall initiated on December 18, 2025
- Stop using product immediately
Browse More Recalls
Safety Guide
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet Alerts for Health & Personal Care Recalls
Get instant alerts for recalls that affect you. Free forever.
